(44- 20) 74 18 84 00 Fax (44- 20) 74 18 86 68 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hos størstedelen af patienterne blev Protaphane sammenlignet med andre typer humant insulin eller insulinanaloger.
In most patients, Protaphane was compared with other types of human insulin or insulin analogues.